Technical Analysis for ANIK - Anika Therapeutics Inc.

Grade Last Price % Change Price Change
grade C 60.04 0.45% 0.27
ANIK closed down 1.26 percent on Thursday, November 14, 2019, on 47 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Earnings due: Dec 1

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Down
See historical ANIK trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.45%
NR7 Range Contraction 0.45%
Stochastic Reached Oversold Weakness 0.45%
Multiple of Ten Bearish Other 0.45%
Wide Bands Range Expansion 0.45%
Oversold Stochastic Weakness 0.45%
Multiple of Ten Bullish Other -0.81%
Wide Bands Range Expansion -0.81%
Up 3 Days in a Row Strength -0.81%
Narrow Range Bar Range Contraction -0.68%

Older signals for ANIK ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Anika Therapeutics, Inc., together with its subsidiaries, develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair. Its products are based on hyaluronic acid (HA), a naturally occurring biocompatible polymer found in the body. The company's products include ORTHOVISC, ORTHOVISC mini, and MONOVISC for the treatment of osteoarthritis of the knee and various other joints; Hyalofast, a biodegradable support for human bone marrow mesenchymal stem cells that is used in connection with soft tissue regeneration; Hyalonect, a woven gauze used as a graft wrap; Hyaloss, HYAFF fibers used to mix blood/bone grafts to form a paste for bone regeneration; and Hyaloglide, an ACP gel used in tenolysis treatment. It also provides wound care products that comprise Hyalomatrix and Hyalofill, for treatment of complex wounds, such as burns and ulcers; and Hyalograft 3D and Laserskin scaffolds for use in connection with the regeneration of skin, as well as ELEVESS, an aesthetic dermatology product for facial wrinkles and scar remediation. In addition, the company offers AMVISC, AMVISC Plus, STAARVISC-II, Optivisc, AnikaVisc, and AnikaVisc Plus that are injectable HA products used as viscoelastic agents in ophthalmic surgical procedures, such as cataract extraction and intraocular lens implantation. Further, it provides Hyalobarrier, a post-operative adhesion barrier; INCERT, a HA product for the prevention of spinal post-surgical adhesions; and Merogel, a woven fleece nasal packing, as well as Merogel Injectable, a viscous hydrogel. Additionally, the company offers HYVISC, an injectable HA product used for the treatment of joint dysfunction in horses. Anika Therapeutics, Inc. markets its products directly, as well as through a network of distributors in the United States, Europe, and internationally. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.
Medicine Stem Cells Osteoarthritis Therapeutic Products Cataract Burns Therapeutic Scar Treatment Of Osteoarthritis Bone Grafting Glycosaminoglycans Hyaluronic Acid Oral And Maxillofacial Surgery Wound Care Products
Is ANIK a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 75.715
52 Week Low 29.01
Average Volume 180,186
200-Day Moving Average 44.6254
50-Day Moving Average 58.2836
20-Day Moving Average 62.5785
10-Day Moving Average 61.996
Average True Range 2.5946
ADX 23.04
+DI 27.5427
-DI 25.9674
Chandelier Exit (Long, 3 ATRs ) 67.9312
Chandelier Exit (Short, 3 ATRs ) 61.7238
Upper Bollinger Band 73.6499
Lower Bollinger Band 51.5071
Percent B (%b) 0.37
BandWidth 35.384038
MACD Line 0.5759
MACD Signal Line 1.4817
MACD Histogram -0.9058
Fundamentals Value
Market Cap 876.11 Million
Num Shares 14.7 Million
EPS 2.25
Price-to-Earnings (P/E) Ratio 26.56
Price-to-Sales 7.22
Price-to-Book 3.29
PEG Ratio 2.68
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 61.50
Resistance 3 (R3) 61.68 61.30 61.21
Resistance 2 (R2) 61.30 60.86 61.20 61.11
Resistance 1 (R1) 60.53 60.59 60.34 60.35 61.02
Pivot Point 60.15 60.15 60.05 60.05 60.15
Support 1 (S1) 59.38 59.71 59.19 59.20 58.52
Support 2 (S2) 59.00 59.44 58.90 58.43
Support 3 (S3) 58.23 59.00 58.33
Support 4 (S4) 58.05